Varicella zoster virus (VZV) in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Pergam, S A ^a,b   Limaye, A P ^b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Herpes zoster; Transplantation; Varicella

Indexed keywords

ACICLOVIR; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; FAMCICLOVIR; GANCICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKA VACCINE; UNCLASSIFIED DRUG; VALACICLOVIR; VARICELLA ZOSTER VACCINE; VZIG;

ANTIVIRAL THERAPY; BACTERIAL SUPERINFECTION; CHICKENPOX; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; DRUG SAFETY; ENCEPHALITIS; GRAFT RECIPIENT; HEPATITIS; HERPES SIMPLEX; HERPES ZOSTER; HERPES ZOSTER OTICUS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; NEUROPATHIC PAIN; ORGAN TRANSPLANTATION; OUTPATIENT CARE; PANCREATITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; TREATMENT DURATION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

ANTIVIRAL AGENTS; CHICKENPOX; HERPES ZOSTER; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 72949088010     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02901.x     Document Type: Review

References (74)

1. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 1994 169 : 91 94.
2. Gnann JW Jr., Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002 347 : 340 346.
3. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000 342 : 635 645.
4. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 56 : 1 40.
5. Heininger U, Seward JF. Varicella. Lancet 2006 368 : 1365 1376.
6. Varicella-related deaths among adults-United States, 1997. MMWR Morb Mortal Wkly Rep 1997 46 : 409 412.
7. Guess HA, Broughton DD, Melton LJ 3rd., Kurland LT. Population-based studies of varicella complications. Pediatrics 1986 78 : 723 727.
8. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005 352 : 450 458.
9. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004 114 : 786 792.
10. Straus SE, Ostrove JM, Inchauspe G et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988 108 : 221 237.
11. Johnson RW. The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 1995 45 : S70 S72.
12. Crespo JF, Gorriz JL, Avila A et al. Prevalence of past varicella zoster virus infection in candidates for kidney transplantation: Vaccination in seronegative patients. Transplant Proc 2002 34 : 77.
13. Geel AL, Landman TS, Kal JA, van Doomum GJ, Weimar W. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc 2006 38 : 3418 3419.
14. Pandya A, Wasfy S, Hebert D, Allen UD. Varicella-zoster infection in pediatric solid-organ transplant recipients: A hospital-based study in the prevaricella vaccine era. Pediatr Transplant 2001 5 : 153 159.
15. Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA. Varicella in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997 1 : 37 42. (Pubitemid 127684806)
16. Rodriguez-Moreno A, Sanchez-Fructuoso AI, Calvo N et al. Varicella infection in adult renal allograft recipients: Experience at one center. Transplant Proc 2006 38 : 2416 2418.
17. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal allograft recipients: Four cases and a review of the literature. Transplantation 2002 73 : 608 611.
18. Feldhoff CM, Balfour HH Jr., Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. J Pediatr 1981 98 : 25 31.
19. McGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC Jr. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 1989 83 : 256 261.
20. Pergam S, Boeckh M, Maynard C, Forsberg C, Limaye A, Young B. Increased Risk of Herpes Zoster in a Multi-center VA Healthcare System Cohort of Solid Organ Transplant Recipients. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Infectious Diseases Society of America Conference, Washington, DC, October 25-28, 2008 Abstract 1330.
21. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: Incidence and risk-factor analysis. Transpl Infect Dis 2008 10 : 260 268.
22. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004 4 : 108 115.
23. Koc Y, Miller KB, Schenkein DP et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000 6 : 44 49.
24. Lauzurica R, Bayes B, Frias C et al. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc 2003 35 : 1758 1759.
25. Geel A, Zuidema W, van Gelder T, van Doornum G, Weimar W. Successful vaccination against varicella zoster virus prior to kidney transplantation. Transplant Proc 2005 37 : 952 953.
26. Fall AJ, Aitchison JD, Krause A, Hasan A, Hamilton JR, Gould FK. Donor organ transmission of varicella zoster due to cardiac transplantation. Transplantation 2000 70 : 211 213.
27. Satoh S, Tada H, Murakami M et al. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation. Transplant Proc 2005 37 : 1751 1753.
28. Volpi A. Severe complications of herpes zoster. Herpes 2007 14 (Suppl 2 35 39.
29. Oh KH, Ahn C, Kim YS et al. Atypical generalized zoster with suspicious esophageal involvement and early relapse in an adult renal transplant recepient. Transplant Proc 2002 34 : 1174 1177.
30. Hovens MM, Vaessen N, Sijpkens YW, de Fijter JW. Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients. Transpl Infect Dis 2007 9 : 237 240.
31. American Academy of Pediatrics. Varicella-Zoster Infections. In : Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book 2006: Report of the Committee on Infectious Diseases, 27th Ed. Elk Grove Village, IL : American Academy of Pediatrics, 2006.
32. Taha YA, Quinlivan M, Scott FT et al. Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains? J Med Virol 2004 73 : 631 635.
33. Coffin SE, Hodinka RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microbiol 1995 33 : 2792 2795.
34. Balfour HH Jr., McMonigal KA, Bean B. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. J Antimicrob Chemother 1983 12 (Suppl B 169 179.
35. Carcao MD, Lau RC, Gupta A, Huerter H, Koren G, King SM. Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J 1998 17 : 626 631.
36. Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986 314 : 208 212.
37. Sulliger JM, Imbach P, Barandun S et al. Varicella and herpes zoster in immunosuppressed children: Preliminary results of treatment with intravenous immunoglobulin. Helv Paediatr Acta 1984 39 : 63 70.
38. Vales-Albertos LJ, Andrade-Sierra J, Gomez-Navarro B et al. Nonspecific immunoglobulin and granulocyte-macrophage colony-stimulating factor use in complicated varicella zoster: The first case report in a renal transplant recipient. Transplantation 2006 81 : 809 810.
39. Tyring S, Belanger R, Bezwoda W, Ljungman P, Boon R, Saltzman RL. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 2001 19 : 13 22.
40. Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. J Infect Dis 2008 197 : 1289 1295.
41. Erard V, Guthrie KA, Varley C et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: No evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007 110 : 3071 3077.
42. Lowance D, Neumayer HH, Legendre CM et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999 340 : 1462 1470.
43. Gane E, Saliba F, Valdecasas GJ et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet 1997 350 : 1729 1733.
44. Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 2006 82 : S9 S14.
45. Fiddian P, Sabin CA, Griffiths PD. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis 2002 186 (Suppl 1 S110 115.
46. Furth SL, Hogg RJ, Tarver J, Moulton LH, Chan C, Fivush BA. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 2003 18 : 33 38. (Pubitemid 36798470)
47. Webb NJ, Fitzpatrick MM, Hughes DA et al. Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child 2000 82 : 141 143.
48. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: Long-term results of vaccination. Pediatrics 1997 99 : 35 39. (Pubitemid 27136599)
49. Kano H, Mizuta K, Sakakihara Y et al. Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation 2002 74 : 543 550.
50. Nithichaiyo C, Chongsrisawat V, Hutagalung Y, Bock HL, Poovorawa Y. Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver disease. Asian Pac J Allergy Immunol 2001 19 : 101 105.
51. Benden C, Danziger-Isakov LA, Astor T et al. Variability in immunization guidelines in children before and after lung transplantation. Pediatr Transplant 2007 11 : 882 887. (Pubitemid 350043290)
52. Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis 2008 197 (Suppl 2 S200 S206.
53. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000 30 : 857 869.
54. ® [package insert]. Whitehouse Station, NJ : Merck & Co., Inc. October 2009.
55. Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006 10 : 78 82.
56. Weinberg A, Horslen SP, Kaufman SS et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006 6 : 565 568.
57. Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994 8 : 190 192.
58. Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988 158 : 238 241.
59. Lopez AS, Burnett-Hartman A, Nambiar R et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008 197 : 646 653.
60. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008 57 : 1 30.
61. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 2006 55 : 209 210.
62. Zaia JA, Levin MJ, Preblud SR et al. Evaluation of varicella-zoster immune globulin: Protection of immunosuppressed children after household exposure to varicella. J Infect Dis 1983 147 : 737 743.
63. Orenstein WA, Heymann DL, Ellis RJ et al. Prophylaxis of varicella in high-risk children: Dose-response effect of zoster immune globulin. J Pediatr 1981 98 : 368 373.
64. Hanngren K, Falksveden L, Grandien M, Lidin-Janson G. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand J Infect Dis 1983 15 : 327 334.
65. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 1993 69 : 639 642 discussion 642-633.
66. Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol 2000 14 : 305 308.
67. Amini H, Javan M, Gazerani P, Ghaffari A, Ahmadiani A. Lack of bioequivalence between two aciclovir tablets in healthy subjects. Clin Drug Invest 2008 28 : 47 53.
68. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983 12 (Suppl B 29 37.
69. Hoglund M, Ljungman P, Weller S. Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients. J Antimicrob Chemother 2001 47 : 855 861.
70. Boeckh M. Prevention of VZV infection in immunosuppressed patients using antiviral agents. Herpes 2006 13 : 60 65.
71. Weinstock DM, Boeckh M, Boulad F et al. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: Unresolved issues. Infect Control Hosp Epidemiol 2004 25 : 603 608. (Pubitemid 38954493)
72. American Academy of Pediatrics Committee on Infectious Diseases: The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 1993 91 : 674 676.
73. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: A household contact study. Jama 2004 292 : 704 708.
74. Hata A, Asanuma H, Rinki M et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002 347 : 26 34.